A NanoLock-enabled, Craspase-based strategy for highly sensitive RNA detection
Nucleic Acids Research · 2025
DOI: 10.1093/nar/gkaf907 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Yumeng Xiao und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Microbial Technology, Shandong University, 72 Binhai Road, Qingdao 266237, China. Hauptthemen laut MEDLINE: SARS-CoV-2, CRISPR-Cas Systems, RNA, Viral, COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Key Technologies Research and Development Program, Key Technology Research and Development Program of Shandong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Rapid and sensitive detection of RNA is important in fields such as biomedical research and clinical diagnostics. However, current methods typically involve an amplification process, require substantial time, and are susceptible to aerosol contamination. Herein, we introduce a NanoLock-powered, amplification-free assay based on the type III-E clustered regularly interspaced short palindromic repeats (CRISPR)–CRISPR-associated system for rapid, highly sensitive, and specific RNA diagnostics. This innovative platform, designated CRISPR-guided caspase (Craspase)–NanoLock–Csx30 (CNC), harmoniously integrates the precise protease activity of Craspase with the remarkable luminescent sensitivity of NanoLock, creating a novel and streamlined approach for RNA detection. The CNC platform exhibited exceptional sensitivity in detecting severe acute respiratory syndrome coronavirus-2 N gene RNA through the integration of three guide RNAs, achieving a detection limit of 250 fM in just 10 min without amplification. Preliminary studies further revealed the platform's extended diagnostic potential for detecting influenza A virus and human immunodeficiency virus. These findings collectively establish the CNC platform as an appealing tool for infectious disease detection and significantly broaden the scope of CRISPR-based diagnostic applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Microbial Technology, Shandong University, 72 Binhai Road, Qingdao 266237, China.
- National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, 15 Datun Road, Beijing 100101, China.
ORCID-Profile: Lichuan Gu
Förderung
- Key Technologies Research and Development Program
- Key Technology Research and Development Program of Shandong Province
- National Natural Science Foundation of China
- Instrument Improvement Funds of Shandong University Public Technology Platform
- Strategic Priority Research Program of the Chinese Academy of Sciences
Zitieren
APA
Xiao, Y., Chen, J., Hou, X., Wang, H., Zhang, K., Xu, S., Jiang, T., Huo, Y., Zhang, F., & Gu, L. (2025). A NanoLock-enabled, Craspase-based strategy for highly sensitive RNA detection. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf907
Vancouver
Xiao Y, Chen J, Hou X, Wang H, Zhang K, Xu S, et al. A NanoLock-enabled, Craspase-based strategy for highly sensitive RNA detection. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf907
BibTeX
@article{Xiao2025,
author = {Xiao, Yumeng and Chen, Junyu and Hou, Xincan and Wang, Hongwei and Zhang, Kundi and Xu, Sujuan and Jiang, Tao and Huo, Yangao and Zhang, Fengyu and Gu, Lichuan},
title = {A NanoLock-enabled, Craspase-based strategy for highly sensitive RNA detection},
journal = {Nucleic Acids Research},
year = {2025},
doi = {10.1093/nar/gkaf907}
}
EUVIMED